EFFECTS OF IMMUNOMODULATION WITH INTERFERON-± ON HEPATIC ISCHEMIA-REPERFUSION INJURY
- 1 May 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Shock
- Vol. 11 (5) , 356-361
- https://doi.org/10.1097/00024382-199905000-00009
Abstract
The development of an inflammatory response after injury depends on the participation of a variety of cell populations and endogenous mediators, lnterferon-± (IFN-±) is a potent cellular immunomodulating cytokine that contributes to acute and chronic inflammation. In this study, the effects of immunomodulation on ischemia-reperfusion injury were examined using increasing doses of recombinant, rabbit-specific IFN-± in an in situ model of hepatic ischemia-reperfusion. Pretreatment with low dose IFN-± augmented injury as measured by histology, aminotransferase concentrations, and myeloperoxidase activity. By contrast, high dose IFN-± pretreatment, equivalent to IFN-± supplements used in clinical trials, resulted in a lack of neutrophil infiltration and minimal progression of late phase, neutrophil-mediated reperfusion injury. These results suggest that immunomodulating mediators such as IFN-± may play a regulating role in the evolution of ischemia-reperfusion, contributing to the development and resolution of acute hepatic injury.Keywords
This publication has 0 references indexed in Scilit: